• by Emil Salazar
  • August 29 2016


Recent FDA and HHS Actions Spur Development of U.S. Zika Test Market

Recent FDA and HHS Actions Spur Development of U.S. Zika Test Market

For further information regarding the U.S. blood screening and global infectious disease diagnostics markets, Kalorama Information offers the recent market research reports United States Market for In Vitro Diagnostic Tests and The World Market for Infectious Disease Diagnostic Tests.

Investigational and emergency authorized Zika virus diagnostics are expected to find rising demand from U.S. customers following the recent expansion of a U.S. Food and Drug Administration (FDA) recommendation, a...

  • by bcarlson@marketresearch.com
  • August 23 2016


IVD Market Exceeds $60BN: New Report

IVD Market Exceeds $60BN: New Report

The global IVD market is currently 60.5 billion dollars, according to Kalorama Information’s recently released report on in vitro diagnostic (IVD) test markets. Kalorama published our tenth edition of its study, The World Market for In Vitro Diagnostic Tests, available at http://bit.ly/2auqUhm After exhaustive study, the report says IVD will grow but in a complex pattern that involves challenges to growth in traditional categories and reliable large markets combined with opportunities in novel t...


Envisioning an Essential Diagnostics List (EDL) and Its IVD Market Impact

Envisioning an Essential Diagnostics List (EDL) and Its IVD Market Impact

Kalorama Information offers relevant market research in the areas of molecular point-of-care (POC) diagnostics , traditional POC diagnostics , and physician office laboratory (POL) test markets. Market information in this post was drawn from the associated reports.

In a recent article of the New England Journal of Medicine (NEJM), health and medical experts convincingly argued for the establishment of an Essential Diagnostics List (EDL) modeled on the existing Essential Medicines List (EML). T...

  • by Emil Salazar
  • August 10 2016


U.S. Hospitals Leverage New IVD Products in the Fight Against Critical Inpatient Infections (AACC 2016)

U.S. Hospitals Leverage New IVD Products in the Fight Against Critical Inpatient Infections (AACC 2016)

This blog post continues Kalorama Information’s coverage of the 2016 AACC Annual Meeting in Philadelphia. Additional coverage of trends in the U.S. IVD market as well as segment market sizes and projections are available with Kalorama’s recent market research report.

With mounting cost pressures on U.S. labs and the growing accountability of diagnostics in critical patient episodes, vendors at the 2016 Annual Meeting of the American Association of Clinical Chemistry (AACC) emphasized solutions...

  • by Emil Salazar
  • August 5 2016


At AACC 2016, Lab Testing Set to Move Forward Through Test and Workflow Automation

At AACC 2016, Lab Testing Set to Move Forward Through Test and Workflow Automation

Proceedings at AACC’s Annual Meeting were notably charged in one way: the proliferation of coffee stands at vendor booths across the expo floor. Vendor demonstrations matched pace as several IVD vendors put their automated testing solutions front and center for speedy sample management and reduced turnaround times. While media attention gravitated to Theranos’ Monday presentation, attendees at Philadelphia were preoccupied with addressing the present challenges of laboratory medicine. Instead of...

  • by bcarlson@marketresearch.com
  • August 3 2016


Retail Clinics an Evident Focus at AACC as #1 IVD Company Presents

Retail Clinics an Evident Focus at AACC as #1 IVD Company Presents

As Kalorama continues to cover the American Association of Clinical Chemistry in Philadelphia on Tuesday, we are tempted to say ’the Empire Strikes back," While Monday’s focus was controversial start-up Theranos, on Tuesday major vendors of the $60 billion-plus in vitro diagnostic industry unveiled their new products, enhancements and plans for existing marketed or in-development devices with a clear pathway for FDA or CE Mark. Kalorama conducted meetings with top-tier vendors and growth compani...

  • by bcarlson@marketresearch.com
  • August 2 2016


AACC Begins: Theranos, IVD Cybersecurity a Focus

AACC Begins: Theranos, IVD Cybersecurity a Focus

AACC, the world’s largest lab professional and IVD convention, began with a large splash -- and more media, crowds, and dare we say, rock music, than a clinical chemistry convention normally sees. Kalorama was live tweeting and will continue to do so thoughout the American Association of Clinical Chemistry Conference in Philadelphia (follow us for updates). This attention to the meeting came as controversial fingerstick test start up Theranos presented to the community of pathologists, lab manag...